| |
|
|
|
Altimmune Inc.  
|
|
2.17 -0.05 (-0.02%) |
09-17 16:00 |
|
Open: |
2.22 |
Pre close: |
2.22 |
Target:
|
2.67
|
|
High: |
2.27 |
Low: |
2.16 |
Resistance:
|
2.29
2.67
|
|
Volume: |
105,261 |
Market Cap: |
33M |
Support:
|
2.07
1.94
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.20
 |
MACD |
MACD(12,26):
|
-0.00  |
|
MA(20): |
2.11 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.38 |
Stochastic Oscillator |
%K(14,3):
|
78.10 |
|
MA(250): |
3.27 |
%D(3): |
76.19 |
|
Average Volume(K) |
3-Month: |
26982
|
52-Week |
High:
|
36.25 |
|
10-Days: |
14310 |
Low: |
1.70 |
|
RSI |
RSI(14):
|
50.92 |
Change(%): |
-49.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.161 |
Return on Equity (ttm) |
-69.9 |
Shares Out. (M) |
15.34 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-13.4 |
Shares Float (M) |
11.67 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.29 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-32.7 |
% Held by Institutions |
1.67 |
|
Forward EPS |
-2.032 |
Gross Profit (p.s.) |
-0.530 |
Shares Short (K) |
1470 |
|
Book Value (p.s.) |
4.280 |
EBITDA (p.s.) |
-0.769 |
P/E |
-0.52 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.35 |
P/S |
27285084.00 |
|
Operating Margin |
-124.58 |
Levered Free Cash Flow
(M) |
-5.97 |
P/CF |
-2.93 |
|
|
|
|
|
|
